Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05694611Phase 3Withdrawn
A Phase 3 trial of sulfur hexafluoride in Prematurity (PTB), sponsored by Turku University Hospital. Planned start Jan 2024; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05694611.